The DOI matches its Crossref record; 92 of the 92 references it cites were found in a registry or an index.
The Nephrotoxicity of Vancomycin
Open accessAbstract
Vancomycin use is often associated with nephrotoxicity. It remains uncertain, however, to what extent vancomycin is directly responsible, as numerous potential risk factors for acute kidney injury frequently coexist. Herein, we critically examine available data in adult patients pertinent to this question. We review the pharmacokinetics/pharmacodynamics of vancomycin metabolism. Efficacy and safety data are discussed. The pathophysiology of vancomycin nephrotoxicity is considered. Risk factors for nephrotoxicity are enumerated, including the potential synergistic nephrotoxicity of vancomycin and piperacillin‐tazobactam. Suggestions for clinical practice and future research are given.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200405-644st · Cited by 5,877
Liu, C., Bayer, A., Cosgrove, S. E., Daum, R. S., Fridkin, S. K., Gorwitz, R. J., Kaplan, S. L., Karchmer, A. W., Levine, D. P., Murray, B. E., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq146 · Cited by 4,191
Rybak, M., Lomaestro, B., Rotschafer, J. C., Moellering, R., Craig, W., Billeter, M., Dalovisio, J. R., & Levine, D. P. (2009) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp080434 · Cited by 1,795
Liu, C., Bayer, A., Cosgrove, S. E., Daum, R. S., Fridkin, S. K., Gorwitz, R. J., Kaplan, S. L., Karchmer, A. W., Levine, D. P., Murray, B. E., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir034 · Cited by 1,599
Hidayat, L. K., Hsu, D. I., Quist, R., Shriner, K. A., & Wong-Beringer, A. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.19.2138 · Cited by 860
The Pharmacokinetic and Pharmacodynamic Properties of Vancomycin
Rybak, M. J. (2006) · Clinical Infectious Diseases · doi:10.1086/491712 · Cited by 774
Arbeit, R. D., Maki, D., Tally, F. P., Campanaro, E., Eisenstein, B. I., & Daptomycin 98-01 and 99-01 Investigators (2004) · Clinical Infectious Diseases · doi:10.1086/420818 · Cited by 689
van Hal, S. J., Paterson, D. L., & Lodise, T. P. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01568-12 · Cited by 639
Lodise, T. P., Lomaestro, B., Graves, J., & Drusano, G. L. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01602-07 · Cited by 574
Wunderink, R. G., Niederman, M. S., Kollef, M. H., Shorr, A. F., Kunkel, M. J., Baruch, A., McGee, W. T., Reisman, A., & Chastre, J. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cir895 · Cited by 570
Lodise, T. P., Patel, N., Lomaestro, B. M., Rodvold, K. A., & Drusano, G. L. (2009) · Clinical Infectious Diseases · doi:10.1086/600884 · Cited by 554
van Hal, S. J., Lodise, T. P., & Paterson, D. L. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cir935 · Cited by 512
Kullar, R., Davis, S. L., Levine, D. P., & Rybak, M. J. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir124 · Cited by 463 · cited 2×
“As expected, however, VANT is associated with increased mortality(50) and length of stay in the ICU(60) and hospital.(50,61) Table 2 Current criteria for diagnosing and staging acute kidney injury”
BackgroundTenover, F. C., & Moellering, R. C. (2007) · Clinical Infectious Diseases · doi:10.1086/513203 · Cited by 452
Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981
Farber, B. F., & Moellering, R. C. (1983) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.23.1.138 · Cited by 432
Steinkraus, G., White, R., & Friedrich, L. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm258 · Cited by 420
Ellis‐Grosse, E. J., Babinchak, T., Dartois, N., Rose, G., Loh, E., & Groups, T. 3. A. 3. C. S. (2005) · Clinical Infectious Diseases · doi:10.1086/431675 · Cited by 414
Are Vancomycin Trough Concentrations Adequate for Optimal Dosing?
Neely, M. N., Youn, G., Jones, B., Jelliffe, R. W., Drusano, G. L., Rodvold, K. A., & Lodise, T. P. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01653-13 · Cited by 392
Nephrotoxicity of vancomycin, alone and with an aminoglycoside
Rybak, M. J., Albrecht, L. M., Boike, S. C., & Chandrasekar, P. H. (1990) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/25.4.679 · Cited by 388
Jeffres, M. N., Isakow, W., Doherty, J. A., Micek, S. T., & Kollef, M. H. (2007) · Clinical Therapeutics · doi:10.1016/j.clinthera.2007.06.014 · Cited by 334
Initial Low‐Dose Gentamicin for Staphylococcus aureus Bacteremia and Endocarditis Is Nephrotoxic
Cosgrove, S. E., Vigliani, G. A., Campion, M., Fowler, Jr., Abrutyn, E., Corey, G. R., Levine, D. P., Rupp, M. E., Chambers, H. F., Karchmer, A. W., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/597031 · Cited by 309
Bosso, J. A., Nappi, J., Rudisill, C., Wellein, M., Bookstaver, P. B., Swindler, J., & Mauldin, P. D. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00168-11 · Cited by 252
Cataldo, M. A., Tacconelli, E., Grilli, E., Pea, F., & Petrosillo, N. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr442 · Cited by 204
Augmented renal clearance in septic patients and implications for vancomycin optimisation
Baptista, J. P., Sousa, E., Martins, P. J., & Pimentel, J. M. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.12.011 · Cited by 193
Hammond, D. A., Smith, M. N., Li, C., Hayes, S. M., Lusardi, K., & Bookstaver, P. B. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/ciw811 · Cited by 189
Navalkele, B., Pogue, J. M., Karino, S., Nishan, B., Salim, M., Solanki, S., Pervaiz, A., Tashtoush, N., Shaikh, H., Koppula, S., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/ciw709 · Cited by 184
Benefits of Therapeutic Drug Monitoring of Vancomycin: A Systematic Review and Meta-Analysis
Ye, Z.-K., Tang, H.-L., & Zhai, S.-D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077169 · Cited by 181
Gomes, D. M., Smotherman, C., Birch, A., Dupree, L., Della Vecchia, B. J., Kraemer, D. F., & Jankowski, C. A. (2014) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1428 · Cited by 180
Vancomycin-associated nephrotoxicity: a critical appraisal of risk with high-dose therapy
Wong-Beringer, A., Joo, J., Tse, E., & Beringer, P. (2011) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2010.10.013 · Cited by 178
A prospective study of adverse reactions associated with vancomycin therapy
Sorrell, T. C., & Collignon, P. J. (1985) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/16.2.235 · Cited by 175
Vancomycin and the Risk of AKI: A Systematic Review and Meta-Analysis
Sinha Ray, A., Haikal, A., Hammoud, K. A., & Yu, A. S. L. (2016) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.05920616 · Cited by 175
Hsu, D. I., Hidayat, L. K., Quist, R., Hindler, J., Karlsson, A., Yusof, A., & Wong-Beringer, A. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.05.007 · Cited by 173
Kalil, A. C., Van Schooneveld, T. C., Fey, P. D., & Rupp, M. E. (2014) · JAMA · doi:10.1001/jama.2014.6364 · Cited by 172
Lodise, T. P., Drusano, G. L., Zasowski, E., Dihmess, A., Lazariu, V., Cosler, L., & McNutt, L.-A. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu398 · Cited by 167
Cano, E. L., Haque, N. Z., Welch, V. L., Cely, C. M., Peyrani, P., Scerpella, E. G., Ford, K. D., Zervos, M. J., Ramirez, J. A., & Kett, D. H. (2012) · Clinical Therapeutics · doi:10.1016/j.clinthera.2011.12.013 · Cited by 161
Increasing Vancomycin Serum Trough Concentrations and Incidence of Nephrotoxicity
Pritchard, L., Baker, C., Leggett, J., Sehdev, P., Brown, A., & Bayley, K. B. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2010.07.025 · Cited by 161
Biomarkers for the Early Detection and Prognosis of Acute Kidney Injury
Malhotra, R., & Siew, E. D. (2017) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01300216 · Cited by 161
Vancomycin-Associated Cast Nephropathy
Luque, Y., Louis, K., Jouanneau, C., Placier, S., Estève, E., Bazin, D. C., Rondeau, É., Letavernier, E., Wolfromm, A., Gosset, C., et al. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016080867 · Cited by 152
Nephrotoxicity of vancomycin and aminoglycoside therapy separately and in combination
Goetz, M. B., & Sayers, J. F. B. (1993) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/32.2.325 · Cited by 145
Megalin Blockade with Cilastatin Suppresses Drug-Induced Nephrotoxicity
Hori, Y., Aoki, N., Kuwahara, S., Hosojima, M., Kaseda, R., Goto, S., Iida, T., De, S., Kabasawa, H., Kaneko, R., et al. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016060606 · Cited by 142
Vancomycin-Associated Nephrotoxicity: Grave Concern or Death by Character Assassination?
Hazlewood, K. A., Brouse, S. D., Pitcher, W. D., & Hall, R. G. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.05.031 · Cited by 139
Nephrotoxicity during Vancomycin Therapy in Combination with Piperacillin-Tazobactam or Cefepime
Rutter, W. C., Cox, J. N., Martin, C. A., Burgess, D. R., & Burgess, D. S. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02089-16 · Cited by 116
Vancomycin-Associated Nephrotoxicity in the Critically Ill
Hanrahan, T. P., Harlow, G., HUTCHINSON, J. H., Dulhunty, J. M., Lipman, J., Whitehouse, T., & Roberts, J. A. (2014) · Critical Care Medicine · doi:10.1097/ccm.0000000000000514 · Cited by 111
Men, P., Li, H.-B., Zhai, S.-D., & Zhao, R. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146224 · Cited by 111
Suzuki, Y., Kawasaki, K., Sato, Y., Tokimatsu, I., Itoh, H., Hiramatsu, K., Takeyama, M., & Kadota, J. (2012) · Chemotherapy · doi:10.1159/000343162 · Cited by 110
Kullar, R., Leonard, S. N., Davis, S. L., Delgado, G., Pogue, J. M., Wahby, K. A., Falcione, B. A., & Rybak, M. J. (2011) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.31.5.441 · Cited by 106
Use of vancomycin in high-flux hemodialysis: Experience with 130 courses of therapy
Barth, R. H., & DeVincenzo, N. (1996) · Kidney International · doi:10.1038/ki.1996.393 · Cited by 106
Larsson, A. J., Walker, K. J., Raddatz, J. K., & Rotschafer, J. C. (1996) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/38.4.589 · Cited by 105
Hammond, D. A., Smith, M. N., Painter, J. T., Meena, N. K., & Lusardi, K. T. (2016) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1738 · Cited by 103
King, D. W., & Smith, M. A. (2004) · Toxicology in Vitro · doi:10.1016/j.tiv.2004.03.013 · Cited by 97
Sader, H. S., Rhomberg, P. R., & Jones, R. N. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00093-09 · Cited by 97
Meaney, C. J., Hynicka, L. M., & Tsoukleris, M. G. (2014) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1423 · Cited by 95
Grace, E. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks066 · Cited by 95
Minejima, E., Choi, J. J., Beringer, P. M., Lou, M., Tse, E., & Wong‐Beringer, A. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00173-11 · Cited by 94
Protective Effects of Different Antioxidants and Amrinone on Vancomycin‐Induced Nephrotoxicity
Çelik, İ., Cihangiroğlu, M., İlhan, N., Akpolat, N., & Akbulut, H. (2005) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2005.pto_153.x · Cited by 92
Moenster, R. P., Linneman, T. W., Finnegan, P. M., Hand, S., Thomas, Z., & McDonald, J. R. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12410 · Cited by 90
Chavada, R., Ghosh, N., Sandaradura, I., Maley, M. W., & van Hal, S. J. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02535-16 · Cited by 90
Vancomycin enhancement of experimental tobramycin nephrotoxicity
Wood, C. A., Kohlhepp, S. J., Kohnen, P. W., Houghton, D. C., & Gilbert, D. N. (1986) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.30.1.20 · Cited by 86
Jensen, J. S., Hein, L., Lundgren, B., Bestle, M. H., Mohr, T. T., Andersen, M. H., Thornberg, K., Løken, J., Steensen, M., Fox, Z. V., et al. (2012) · BMJ Open · doi:10.1136/bmjopen-2011-000635 · Cited by 84
Steinmetz, T., Eliakim‐Raz, N., Goldberg, E., Leibovici, L., & Yahav, D. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.04.003 · Cited by 81
Giuliano, C. A., Patel, C., & Kale-Pradhan, P. B. (2016) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1851 · Cited by 80
Toxicology of Vancomycin in Laboratory Animals
Wold, J. S., & Turnipseed, S. A. (1981) · Clinical Infectious Diseases · doi:10.1093/clinids/3.supplement_2.s224 · Cited by 77
Sakamoto, Y., Yano, T., Hanada, Y., Takeshita, A., Inagaki, F., Masuda, S., Matsunaga, N., Koyanagi, S., & Ohdo, S. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.02.025 · Cited by 77
Pulmonary disposition of vancomycin in critically ill patients
Georges, H., Leroy, O., Alfandari, S., Guery, B. P., Roussel‐Delvallez, M., Dhennain, C., & Beaucaire, G. (1997) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01726369 · Cited by 74
Horey, A., Mergenhagen, K. A., & Mattappallil, A. (2012) · Annals of Pharmacotherapy · doi:10.1345/aph.1r158 · Cited by 68
Vancomycin therapeutics and monitoring: a contemporary approach
Avent, M. L., Vaska, V. L., Rogers, B. A., Cheng, A. C., van Hal, S. J., Holmes, N. E., Howden, B. P., & Paterson, D. L. (2012) · Internal Medicine Journal · doi:10.1111/imj.12036 · Cited by 68
Kim, T., Kandiah, S., Patel, M., Rab, S., Wong, J. R., Xue, W., Easley, K. A., & Anderson, A. M. L. (2015) · BMC Research Notes · doi:10.1186/s13104-015-1518-9 · Cited by 67
Karino, S., Kaye, K. S., Navalkele, B. D., Nishan, B., Salim, M., Solanki, S., Pervaiz, A., Tashtoush, N., Shaikh, H., Koppula, S., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03011-15 · Cited by 63
Factors Associated with Vancomycin Nephrotoxicity in the Critically Ill
Hanrahan, T. P., Kotapati, C., Roberts, M. J., Rowland, J. L., Lipman, J., Roberts, J. A., & Udy, A. A. (2015) · Anaesthesia and Intensive Care · doi:10.1177/0310057x1504300507 · Cited by 62
Hanrahan, T. P., Whitehouse, T., Lipman, J., & Roberts, J. A. (2015) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2015.04.013 · Cited by 62
Song, K., Kim, H. B., Kim, H.-S., Lee, M. J., Jung, Y., Kim, G., Hwang, J.-H., Kim, N., Kim, M., Kim, C.-J., et al. (2015) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2015.09.010 · Cited by 62
Prevention of vancomycin induced nephrotoxicity: a review of preclinical data
Elyasi, S., Khalili, H., Hatamkhani, S., & Dashti‐Khavidaki, S. (2012) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-012-1406-3 · Cited by 59
Hale, C. M., Seabury, R. W., Steele, J. M., Darko, W., & Miller, C. (2016) · Journal of Pharmacy Practice · doi:10.1177/0897190016642692 · Cited by 59
Tongsai, S., & Koomanachai, P. (2016) · BMC Research Notes · doi:10.1186/s13104-016-2252-7 · Cited by 59
Hall, R. G., Hazlewood, K. A., Brouse, S. D., Giuliano, C. A., Haase, K. K., Frei, C. R., Forcade, N. A., Bell, T., Bedimo, R., & Álvarez, C. A. (2013) · BMC Pharmacology and Toxicology · doi:10.1186/2050-6511-14-12 · Cited by 55
A Randomized Trial of Loading Vancomycin in the Emergency Department
Rosini, J. M., Laughner, J., Levine, B. J., Papas, M. A., Reinhardt, J. F., & Jasani, N. B. (2014) · Annals of Pharmacotherapy · doi:10.1177/1060028014556813 · Cited by 54
Hsu, S. I. (2001) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.21.15.1233.33901 · Cited by 49
Medication Reconciliation and Hypertension Control
Persell, S. D., Bailey, S. C., Tang, J. Z., Davis, T. C., & Wolf, M. S. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.06.027 · Cited by 47
Ghosh, N., Chavada, R., Maley, M. W., & van Hal, S. J. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12695 · Cited by 47
Vancomycin Use in Patients Requiring Hemodialysis: A Literature Review
Cardone, K. E., & Manley, H. J. (2007) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2007.00333.x · Cited by 46
Mavros, M. N., Tansarli, G. S., Vardakas, K. Z., Rafailidis, P. I., Karageorgopoulos, D. E., & Falagas, M. E. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2012.07.023 · Cited by 44
Impact of an Antimicrobial Stewardship Program on Patient Safety in Veterans Prescribed Vancomycin
Fodero, K. E., Horey, A., Krajewski, M. P., Ruh, C. A., Sellick, J. A., & Mergenhagen, K. A. (2016) · Clinical Therapeutics · doi:10.1016/j.clinthera.2016.01.001 · Cited by 37
Elevated vancomycin trough is not associated with nephrotoxicity among inpatient veterans
Prabaker, K. K., Tran, T. P. ‐., Pratummas, T., Goetz, M. B., & Graber, C. J. (2011) · Journal of Hospital Medicine · doi:10.1002/jhm.946 · Cited by 36
The pharmacokinetic/pharmacodynamic rationale for administering vancomycin via continuous infusion
Waineo, M. F., Kuhn, T. C., & Brown, D. L. (2015) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.12270 · Cited by 36
Crew, P. E., Heintz, S. J., & Heintz, B. H. (2015) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp150051 · Cited by 35
Contreiras, C., Legal, M., Lau, T. T. Y., Thalakada, R., Shalansky, S. J., & Ensom, M. H. H. (2014) · The Canadian Journal of Hospital Pharmacy · doi:10.4212/cjhp.v67i2.1340 · Cited by 33
The association of elevated trough serum vancomycin concentrations with obesity
Richardson, J., Scheetz, M. H., & O’Donnell, E. P. (2015) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2015.03.007 · Cited by 29
Davies, S. W., Guidry, C. A., Petroze, R. T., Hranjec, T., & Sawyer, R. G. (2013) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0b013e3182a74b70 · Cited by 28
Carreno, J. J., Kenney, R. M., Divine, G., Vázquez, J. A., & Davis, S. L. (2016) · Annals of Pharmacotherapy · doi:10.1177/1060028016673858 · Cited by 23
Vancomycin Pharmacokinetics and Pharmacodynamics during Short Daily Hemodialysis
Decker, B. S., Kays, M. B., Chambers, M., Kraus, M. A., Moe, S. M., & Sowinski, K. M. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03450410 · Cited by 18
Biopsy-Proven Acute Tubular Necrosis Associated with Vancomycin in an Adult Patient
Belen, C., Budhiraja, P., Bracamonte, E. R., & Popovtzer, M. M. (2012) · Renal Failure · doi:10.3109/0886022x.2012.655683 · Cited by 16
Rosini, J. M., Davis, J. J., Muenzer, J. R., Levine, B. J., Papas, M. A., Comer, D., & Arnold, R. (2016) · Academic Emergency Medicine · doi:10.1111/acem.12934 · Cited by 14
Cited by
Branch-Elliman, W., O’Brien, W., Strymish, J., Itani, K., Wyatt, C., & Gupta, K. (2019) · JAMA Surgery · doi:10.1001/jamasurg.2019.0569 · Cited by 381
Drug-Induced Acute Kidney Injury
Perazella, M. A., & Rosner, M. H. (2022) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.11290821 · Cited by 357
Podlesny, D., Durdevic, M., Paramsothy, S., Kaakoush, N. O., Högenauer, C., Gorkiewicz, G., Walter, J., & Fricke, W. F. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100711 · Cited by 111
Pan, K., Li, R., Li, Y., Ding, X., Li, X., & Lv, Q. (2025) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkae410 · Cited by 16
Metadata
- Authors
- Filippone, E., Kraft, W., & Farber, J.
- Venue
- Clinical Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2017-06-05
- Volume
- 102
- Issue
- 3
- Pages
- 459-469
- ISSN
- 0009-9236 (ISSN-L)
- 1532-6535
- OpenAlex
- W2610895230
- Cited by
- 416
- References
- 92
- FWCI
- 20.58
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.